Procedural results and late clinical outcomes following multivessel coronary stenting
Ran Kornowski, MDa,
Roxana Mehran, MD, FACCa,
Lowell F. Satler, MD, FACCa,
Augusto D. Pichard, MD, FACCa,
Kenneth M. Kent, MD, FACCa,
Ann Greenberg, RNa,
Gary S. Mintz, MD, FACCa,
Mun K. Hong, MD, FACCa and
Martin B. Leon, MD, FACCa
a Cardiac Catheterization Laboratory, Division of Cardiology, Washington Hospital Center, Washington, D.C., USA
View larger version (130K):
[in a new window]
|
Figure 1 A representative angiogram of a 47-year-old patient with unstable angina reveals two-vessel disease. The left anterior descending lesions (arrows) were successfully treated using two overlapping stents. The right coronary artery angiogram showed a diffuse lesion extending from the proximal to mid segment artery (arrows), successfully treated with three overlapping stents.
|
|
View larger version (12K):
[in a new window]
|
Figure 2 Actuarial event-free survival curves for any adverse event (death, Q-wave MI, angioplasty or CABG, upper panel) up to 18 months following one-time percutaneous treatment of single versus multivessel disease.
|
|
|
